A recommendation for high-dose Ara-C interval treatment based on studies in a slow-growing leukemia model (BNML)
Open Access
- 1 January 1982
- journal article
- research article
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 10 (S1) , 209-219
- https://doi.org/10.1002/mpo.2950100721
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- A randomized clinical trial of remission induction, consolidation, and chemo-immunotherapy maintenance in adult acute myeloblastic leukemiaCancer Immunology, Immunotherapy, 1978
- Introduction of the BN myelocytic leukaemiaLeukemia Research, 1977
- Treatment of acute nonlymphocytic leukemia in elderly patients.A prospective study of intensive chemotherapyCancer, 1977
- Cellular Quantitation of In Vivo Effects of 1-β-d-Arabinofuranosylcytosine on Leukemia L12102JNCI Journal of the National Cancer Institute, 1977
- The Appearance of the Multipotential Hemopoietic Stem CellPublished by Springer Nature ,1977
- Sequential use of methotrexate, folinic acid, and cytosine arabinoside in the treatment of acute leukemiaPublished by Elsevier ,1976
- Early consolidation chemotherapy for adults with acute leukemia in remissionMedical and Pediatric Oncology, 1976
- Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemiaCancer, 1975
- Treatment of acute leukemia in adultsCancer, 1975
- Prolonged infusion of arabinosyl cytosine in childhood leukemiaCancer, 1970